Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC

Clinical trial NCT00469443 · COMPLETED

Trial details

NCT number: NCT00469443
Sponsor: Hellenic Oncology Research Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2006-12-01
Primary completion: 2010-02-01
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.